PCAS, a French specialist in complex molecules for the life sciences and specialty chemicals markets, has received an offer for its Canadian subsidiary from Japanese...

French API specialist Seqens is investing what it says is a multi-million-dollar sum in its US research and development laboratory at Devens, Massachusetts. The company...

Private equity group SK Capital Partners has completed the acquisition of a majority stake in French firm Seqens, at the same time merging portfolio company Wavelength...

Seqens, a French provider of pharmaceutical synthesis and specialty ingredients, is planning to invest an undisclosed sum in a second isopropanol (IPA) production plant...